Skip to main content
    L

    Lexaria Bioscience Corp (LEXX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $4.18
    -0.23 (-5.22%)

    Market Cap: $9.35M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Lexaria Bioscience Corp (LEXX) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Lexaria Bioscience (LEXX) has a latest price of $4.18 on Nov 17, 2026, 80.6% below its 52-week high of $21.60. Its price fell 73.7% over the past 12 months. The month-end price fell 97.5% since Dec 2016, a compound annual decline of 31.3%.

    Price Chart

    From Dec 2016 to Oct 2026, its highest month-end close was $922.96 in Aug 2018 and its lowest $3.15 in Sep 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart LEXX with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for LEXX.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 63.7%, and over 6 months it fell 51.7%. The month-end price fell 83.1% over the 3 years through Oct 2026, a compound annual decline of 44.7%.

    PeriodChange
    1 month+60.8%
    3 months-63.7%
    6 months-51.7%
    12 months-73.7%
    12 months, with dividends-73.7%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-83.1%-44.7%
    5 years-96.2%-48.1%
    Since Dec 2016-97.5%-31.3%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2017, when the price rose 445.2%, and its weakest was 2025, when it fell 70.6%.

    YearCloseChange
    2026 through Oct 2026$3.49-62.3%
    2025$9.25-70.6%
    2024$31.48+68.0%
    2023$18.74-49.2%
    2022$36.88-39.0%
    2021$60.42-46.2%
    2020$112.24-34.4%
    2019$171.09-59.1%
    2018$418.71-45.0%
    2017$760.88+445.2%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 18.7% above its 50-day average of $3.52 and 50.9% below its 200-day average of $8.51.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$4.18
    52-week high$21.60-80.6%
    52-week low$2.43+72.0%
    50-day average$3.52+18.7%
    200-day average$8.51-50.9%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 97.2%.

    MeasureValue
    1-year beta0.80
    Largest fall, 1 year-87.1%
    Largest fall, 3 years-97.2%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About LEXX

    What is LEXX's 1-year price change?

    Lexaria Bioscience's price fell 73.7% over the past 12 months. With dividends included, the 12-month total return was -73.7%.

    What is LEXX's 5-year price change?

    Lexaria Bioscience's month-end price fell 96.2% over the 5 years through Oct 2026, a compound annual decline of 48.1%. These figures leave out dividends.

    What is LEXX's 52-week high and low?

    Lexaria Bioscience's 52-week high is $21.60 and its 52-week low is $2.43. Its latest price of $4.18 on Nov 17, 2026 is 80.6% below the high.

    What is LEXX's beta?

    Lexaria Bioscience's 1-year beta against the S&P 500 is 0.80, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 87.1%.

    Is the LEXX chart free?

    Yes. Advanced Charting for LEXX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.